J.O. Emembolu

No ORCID on file · 4 papers in corpus
nonrandomized-trial 2011
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.02.013

OBJECTIVES: The levonorgestrel (LNG) intrauterine system (LNG-IUS) has been shown to improve symptoms in women with minimal to moderate endometriosis. The precise mechanism for this is unknown. We hypothesized that this involves alteration …

nonrandomized-trial 2011
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2011.09.007

OBJECTIVES: Mirena® has been shown to improve symptoms in women with minimal to moderate endometriosis. The precise mechanisms for this have not been thoroughly investigated. We investigate here one possible mechanism-alteration in the numb…

nonrandomized-trial 2005
·doi:10.1097/01.ogx.0000167406.63373.53

Most treatments used to date for endometriosis cause systemic side effects that not only may reduce compliance, but also preclude their long-term use. The levonorgestrel intrauterine system, which delivers the progestogen levonorgestrel dir…

nonrandomized-trial 2004
Human Reproduction ·doi:10.1093/humrep/deh650

BACKGROUND: Side-effects and choice of drugs influence compliance during treatment for endometriosis. Progestogen administered by a device with a 5-year lifespan, has been shown to be an effective medical alternative with several advantages…